non-Sq@Pembro+CBDCA+PEM
€–Ϊ–Ό Šξ€—Κ ’PˆΚ }ަ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 @ @ @ @ @ @ @
‘S‘ΜƒXƒPƒWƒ…[ƒ‹ œ ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x @ @ @ @ @ @ @
ƒLƒCƒgƒ‹[ƒ_ 200 mg š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒAƒŠƒ€ƒ^ 500 mg/‡u š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒJƒ‹ƒ{ƒvƒ‰ƒ`ƒ“ 5 AUC š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
y’ˆΣƒ`ƒ…ƒEƒCŽ–€ƒWƒRƒEz